Cellipont Bioservices

Overview

Cellipont Bioservices is a specialized cell therapy Contract Development and Manufacturing Organization (CDMO) dedicated to advancing cell therapy development and manufacturing for clients worldwide. The company operates a purpose-built cGMP manufacturing facility in The Woodlands, Texas, designed to support a wide range of cell therapy modalities with flexible, segregated environments.

Core Services

Process Development & Analytical Development

• Technology transfer from research to GMP environments
• Process optimization and scale-up support
• Full process comparability and method readiness
• Gap analyses and risk mitigation
• Lifecycle management across multiple clinical phases

Clinical Manufacturing

• cGMP manufacturing for autologous and allogeneic cell therapies
• Segregated manufacturing suites for different workflow types
• Controlled sterile processing and fill/finish environments
• Scalable equipment platforms supporting clinical-grade volumes
• Flexible "Ballroom-style Flex Suite" for emerging technologies including exosomes

Quality Control & Compliance

• On-site QC laboratories
• Rigorous GMP protocols for facility management, documentation, and process control
• FDA and EMA compliance systems designed for global product registration
• Comprehensive documentation and batch-record processes
• Method validation and stability programs

Modality Expertise

Cellipont has proven hands-on experience across multiple cell therapy product areas:

• CAR-T and TCR-T therapies
• Allogeneic and autologous cell therapies
• iPSC-derived programs
• Gene-modified products
• NK cells and T-cell subsets
• Dendritic cells (DCs)
• Fibroblasts
• Mesenchymal stem cells (MSCs)
• Hematopoietic stem cells (HSCs)
• Tumor-infiltrating lymphocytes (TIL)
• Cell banking (MCB, WCB) and feeder cell banks
• Exosome manufacturing

Facility & Infrastructure

The purpose-built facility features:

• Segregated manufacturing suites for autologous and allogeneic workflows
• Controlled sterile processing and fill/finish environments
• On-site quality control laboratories
• Scalable equipment platforms
• Flexible infrastructure supporting multiple modalities and batch sizes
• Automated, fully closed manufacturing workflows

Regulatory & Quality Framework

Cellipont adheres to US and EU cGMP frameworks with:

• Robust quality systems and comprehensive documentation
• FDA and EMA compliance alignment
• ICH guideline adherence
• Continuous quality oversight and batch-record processes
• Regulatory support throughout development and commercialization

Client Support

The company emphasizes end-to-end capabilities, deep scientific expertise, client-centric collaboration, and transparent communication throughout program development. The team has decades of hands-on cell therapy experience and is recognized by partners for successful manufacturing and product release.